Semaglutide (scientific grade)

Smeglutide is a humanized GLP-1 (glucagon like peptide-1) receptor agonist, which belongs to long-acting peptide metabolism regulation molecule and is widely used in basic research of type II diabetes, obesity and related metabolic diseases. Its molecular design is based on natural GLP-1, which has high affinity, long half-life, and high resistance to DPP-4 enzyme degradation, making it suitable for chronic animal experiments and mechanism intervention research.